Creating a New Kind of Doctor
We recruit and train physician leaders as comfortable taking on systemic challenges in health as caring for individual patients.
Discovery to Impact — Faster
We reward creative thinking and encourage rapid experimentation, using collaborative programs to speed promising research to market.
Improving Care. Improving Health.
We’re here to make health — including health care — better. The end goal is a complete revolution in how people get and stay healthy.
In This Section
More Information
Health in the Landscape of Life
Enabling the healthscape, the ecosystem outside the clinic, requires improving the system to pay for health drivers.
More Information
Meet Dell Med
We’re rethinking the role of academic medicine in improving health — and doing so with a unique focus on our community.
More Information
Make an Appointment Faculty Students Directory Give

Kyaw Aung, M.D., Ph.D.

UT Health Austin Care Team Member


Kyaw Lwin Aung, M.D., Ph.D., is a medical oncologist and a physician scientist in UT Health Austin’s Livestrong Cancer Institutes. He is also a part of both UT Health Austin’s Hereditary Cancer Screening and Risk Reduction care team and UT Health Austin’s CaLM Care Team. He specializes in treating patients with gastrointestinal cancers. Additionally, Aung is an assistant professor in the Dell Medical School Department of Oncology. Aung earned his medical degree from the University of Medicine 1, Yangon in Myanmar and his doctorate from The University of Manchester in the United Kingdom. He completed a residency in internal medicine at Lincoln County Hospital in the United Kingdom, a fellowship in medical oncology at Clatterbridge Cancer Center in Liverpool and a second fellowship in early phase oncology drug development and gastrointestinal cancers at Princess Margaret Cancer Center/the University of Toronto in Canada.

Aung’s mission is to deliver the best possible patient-centered multidisciplinary care to patients with gastrointestinal cancers and to find new therapies for patients with pancreatic cancer. His laboratory research focuses on understanding pancreatic cancer biology to develop novel personalized treatment strategies for patients with pancreatic cancer. He has published multiple peer-reviewed research papers in the field of oncology.